1. Clinical Overview
Xylometazoline is a potent, direct-acting sympathomimetic amine used as a topical nasal decongestant. It is a selective alpha-2 adrenergic receptor agonist, causing vasoconstriction of the dilated arterioles in the nasal mucosa, leading to reduced blood flow, decreased edema, and relief of nasal obstruction. The 0.65% w/v concentration is a standard adult formulation in India, available as a nasal spray or drops. It provides rapid symptomatic relief in allergic and inflammatory rhinitis but is not a curative treatment.
| Onset | Duration | Bioavailability |
|---|---|---|
| 5-10 minutes | 8-12 hours | Negligible systemic absorption when used intranasally at recommended doses. |
2. Mechanism of Action
Xylometazoline acts as a potent and selective agonist on postsynaptic alpha-2 adrenergic receptors located on vascular smooth muscle cells within the nasal mucosa. This activation stimulates the G-protein coupled receptor, leading to activation of phospholipase C and increased intracellular inositol triphosphate (IP3). The rise in IP3 triggers the release of calcium from the sarcoplasmic reticulum, resulting in smooth muscle contraction and vasoconstriction of the capacitance vessels (venous sinusoids) and arterioles. This reduces blood flow, capillary permeability, and mucosal edema, thereby shrinking the nasal turbinates and improving airway patency.
3. Indications & Uses
- Symptomatic relief of nasal congestion associated with Allergic Rhinitis (Seasonal & Perennial)
- Symptomatic relief of nasal congestion in Acute Rhinosinusitis and the Common Cold
4. Dosage & Administration
Adult Dosage: 2-3 drops or 1 spray (approx. 0.1 mL) into each nostril. May be repeated every 8 to 10 hours as needed. DO NOT exceed 3 doses in 24 hours.
Administration: 1. Blow nose gently to clear nostrils. 2. Tilt head slightly back. 3. Insert nozzle just inside nostril, pointing away from the nasal septum. 4. Squeeze bottle for spray or dropper for drops while breathing in gently through the nose. 5. Avoid touching nozzle to nasal surface to prevent contamination. 6. Do not share the bottle.
5. Side Effects
Common side effects may include:
- Transient mild burning, stinging, or dryness of nasal mucosa
- Sneezing
- Mild headache
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Monoamine Oxidase Inhibitors (MAOIs) - e.g., Phenelzine, Tranylcypromine | Potentiation of pressor effects, leading to severe hypertensive crisis. | Contraindicated |
| Tricyclic Antidepressants (TCAs) - e.g., Amitriptyline, Imipramine | May potentiate the pressor effects of xylometazoline. | Major |
| Other Sympathomimetics (e.g., Pseudoephedrine, Phenylephrine oral) | Additive sympathomimetic effects, increasing risk of tachycardia and hypertension. | Moderate |
| Beta-blockers (non-selective) - e.g., Propranolol | Unopposed alpha-adrenergic activity may lead to severe hypertension and bradycardia. | Moderate |
| Methyldopa | Possible increased pressor response. | Moderate |
7. Patient Counselling
- DO use only for the prescribed duration (max 5-7 days).
- DO blow your nose gently before use.
- DO clean the nozzle tip with a tissue after each use.
- DO NOT use more than 3 times a day or for longer than one week.
- DO NOT share your nasal spray with anyone.
- DO NOT tilt your head too far back to prevent drainage into the throat.
- DO NOT use if the solution is discolored or contains particles.
8. Toxicology & Storage
Overdose: **Topical Overuse:** Severe rebound congestion, nasal dryness/irritation, headache. **Systemic Overdose (esp. in children from accidental ingestion):** CNS depression (drowsiness, lethargy, coma), bradycardia, hypotension (may be preceded by transient hypertension), hypothermia, apnea, miosis.
Storage: Store at room temperature (15-25°C). Protect from light and excessive heat. Do not freeze. Keep the bottle tightly closed. Keep out of reach and sight of children. Discard 28 days after first opening (for multi-dose containers) to prevent microbial contamination.